Fig. 4

cPLA2 and p-cPLA2 levels in the brains of persons with different APOE genotypes. a, p-cPLA2, and cPLA2 protein levels in the inferior frontal cortex from persons with NCI were detected by WB (left). Densitometric quantification of the blotting (right). b, p-cPLA2, and cPLA2 protein levels in the inferior frontal cortex from AD patients were detected by WB. Densitometric quantification of the blotting (right). WB: Western Blot